Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aura Biosciences (AURA) Retained Earnings (2020 - 2026)

Aura Biosciences filings provide 7 years of Retained Earnings readings, the most recent being -$207000.0 for Q1 2026.

  • Quarterly Retained Earnings rose 99.95% to -$207000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$207000.0 through Mar 2026, up 99.95% year-over-year, with the annual reading at -$480.4 million for FY2025, 182768.44% down from the prior year.
  • Retained Earnings hit -$207000.0 in Q1 2026 for Aura Biosciences, up from -$480.4 million in the prior quarter.
  • Across five years, Retained Earnings topped out at $263000.0 in Q4 2024 and bottomed at -$480.4 million in Q4 2025.
  • Average Retained Earnings over 5 years is -$171.0 million, with a median of -$194.3 million recorded in 2022.
  • The largest annual shift saw Retained Earnings crashed 4567900.0% in 2023 before it surged 113.66% in 2025.
  • Aura Biosciences' Retained Earnings stood at -$72000.0 in 2022, then crashed by 398938.89% to -$287.3 million in 2023, then soared by 100.09% to $263000.0 in 2024, then tumbled by 182768.44% to -$480.4 million in 2025, then surged by 99.96% to -$207000.0 in 2026.
  • Per Business Quant, the three most recent readings for AURA's Retained Earnings are -$207000.0 (Q1 2026), -$480.4 million (Q4 2025), and -$454.9 million (Q3 2025).